MMJ Recs

APRIL 30, 2024

Marijuana Processing Techniques Once the cannabis plants reach maturity, they undergo processing to extract the beneficial compounds, such as cannabinoids and terpenes. Common methods include solvent extraction, such as using ethanol or CO2, to isolate cannabinoids like THC and CBD.

Cultivation 52

Cultivation Supply Chain Extraction Marijuana 52

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 105

Medicine Research and Development Agriculture Strains 105

Project CBD

JULY 28, 2023

From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development. He has guided clients on license applications, facility design and build out, equipment installation and optimization, and plant oil extraction for cannabis and hemp processing facilities. — that are widely available.

THC 212

THC Cannabinoids Hemp Research and Development 212

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Kind Meds (Cannabis Education Blog)

JANUARY 27, 2022

Lately, the cannabinoid CBN (or cannabinol) has been rising in popularity. CBN is a cannabinoid that can be synthesized out of THC. Cannabinol – more commonly known as CBN – is one of over one hundred cannabinoids found in the cannabis plant. The CBN cannabinoid begins to form when THC is oxidized. What Is CBN Extraction?

Cannabinoids 52

Cannabinoids Treatment Extraction THC 52

MMJ Recs

APRIL 25, 2024

It encompasses several essential steps aimed at nurturing and optimizing plant growth and development: Seed Selection and Germination: The process begins with the careful selection of quality seeds, which are crucial for cultivating premium medical marijuana strains. Select seeds from reputable breeders known for producing stable genetics.

Marijuana 52

Marijuana Cultivation Safety Trichome 52

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Veriheal

JANUARY 18, 2022

A team of University of Oregon-affiliated researchers has uncovered an unlikely tool in the fight against COVID-19. Specifically, the team identified the cannabinoid acids cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA) as the compounds that could effectively combat the virus. What do you think of the study’s findings?

Research and Development 104

Research and Development Cannabinoids Extraction Hemp 104

Cannabis Law Report

JULY 13, 2021

Inhalation of cannabis extracts allows for a faster onset and higher bioavailability than tinctures and oils, and now that doctors can monitor a patient’s metered-dosage, more accurate patient data. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.

Extraction 105

Extraction Vaping Medicine Patients 105

Cannabis Law Report

NOVEMBER 23, 2021

(OTC PINK:CBGL), an innovation-oriented company investing in disruptive cannabis technologies, today announces an important enhancement to its cannabis product manufacturing capabilities at its Natural Plant Extract of California facility in Lynwood, a suburb of Los Angeles.

Extraction 52

Extraction Research and Development Concentrates Edibles 52

Veriheal

AUGUST 16, 2021

The National Football League has taken proactive steps moving forward into the future with a research grant to explore potential therapeutic attributes of CBD, cannabis, and other options to treat pain other than opioids. NFL Research Grant Will Invest in a Bright Future for Athletes and Others. The opioid epidemic is real.

Therapy 104

Therapy Chronic Pain Research and Development Treatment 104

SpeedWeed

JULY 23, 2021

Denver is expanding Alzheimer’s research through the efforts of local company MedPharm. . The company plans to move forward with research efforts through a special Schedule I Researcher Licenses given specifically to the company by the Drug Enforcement Administration. Denver Company Moves Forward with Research License .

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

The Joint Blog

OCTOBER 12, 2022

Many conversations surrounding cannabis and its cannabinoids often revolve around only a few primary compounds. As such, many people who use cannabis products are more likely to recognize these cannabinoids than others. One of these cannabinoids, HHC, is slowly but indeed increasing on the market. and its various cannabinoids.

Cannabinoids 49

Cannabinoids Research and Development THC Extraction 49

Cannabis Law Report

APRIL 17, 2022

billion) annually to state revenue, Minister for Development and Investment Adonis Georgiadis said, according to greekreporter.com. The two major cannabinoids extracted from this plant that provide medical benefits include tetrahydrocannabinol (THC) and cannabidiol (CBD). billion euros ($1.67

Research and Development 52

Research and Development Chronic Pain Recreational Environment 52

Cannabis Law Report

NOVEMBER 17, 2021

Launch of Zylem ™ 20:1 further expands ZYUS product offerings with new cannabinoid formulation. The launch of this formulation marks an important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Extraction 52

Cannabis Law Report

OCTOBER 4, 2021

A major component of the program will be the development of new ways to infuse both the psychedelic compounds and fungi components into products to both improve bioavailability and to mask the bitter tastes of the fungus and its components.

Food 52

Food Programs Research and Development Collective 52

Cannabis Law Report

JANUARY 16, 2020

(“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this.

Extraction 64

Extraction Pharmaceutical Research and Development Terpenes 64

SpeedWeed

MARCH 13, 2021

“This exciting opportunity to be a part of the state’s regulated Cannabinoid Hemp Program is great news for farmers and consumers.”. In accordance with legislation signed last year by the Governor, the Department has created a Cannabinoid Hemp Program.

Cannabinoids 52

Cannabinoids Programs Hemp Business 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

DECEMBER 1, 2021

Cannabis and Life Sciences Company Initiates Internal Study Comparing Anti-Inflammatory Properties of Candidate JUVA-019 When Combined With Cannabinoids Such as THC and CBD. The study will be conducted in-house via Juva’s research team, led by Dr. Sanjeev Gangwar, Ph.D., November 30, 2021 04:00 ET | Source: Juva Life Inc.

Cannabinoids 52

Cannabinoids Research and Development Pharmaceutical THC 52

Cannabis Law Report

FEBRUARY 1, 2022

New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing. The launch of these two new softgel products marks another important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Media 52

Cannabis Law Report

JUNE 17, 2021

Trait”) — a global leader in cannabinoid research focused on developing technologies that enable the production of safe, high-quality, predictable, and efficacious CBD products — today announced the completion of a C$31 million Series A financing round (the “Financing”). ” src=”cid:image004.jpg@01D7629A.47F4A520″

Research and Development 105

Research and Development Cannabinoids Extraction CBD 105

SpeedWeed

MAY 14, 2021

The US National Institute on Drug Abuse (NIDA) has established a standard dose for THC , a decision that will help medical cannabis researchers compare the results of new clinical studies. . Last March, NIDA published a notice asking scientists and researchers for advice on creating an optimal standard dose for THC.

THC 52

THC Research and Development Strains Cannabinoids 52

Healer

MAY 25, 2021

While neutral cannabinoids have gotten a lot of attention, new studies show that cannabinoids in their original acidic form have tremendous healing properties that act in tandem with and in contrast to their neutral counterparts. In this article, I share what we know about acidic cannabinoids today and why you should incorporate them.

Cannabinoids 52

Cannabinoids THC Research and Development CBD 52

Healer

MAY 25, 2021

While neutral cannabinoids have gotten a lot of attention, new studies show that cannabinoids in their original acidic form have tremendous healing properties that act in tandem with and in contrast to their neutral counterparts. In this article, I share what we know about acidic cannabinoids today and why you should incorporate them.

Cannabinoids 52

Cannabinoids THC Research and Development CBD 52

Medicinal Genomics

JULY 11, 2018

Their goal was to disrupt the hemp extract market by breeding CBD-rich plants derived from medicinal cannabis plants that would replace the low-cannabinoid, low-terpene producing fibrous hemp plants that were being used to make extracts. Crawford discussed OregonCBD’s newest cultivar group, CBG-rich plants (Type IV).

Extraction 81

Extraction Hemp Seed-To-Sale Terpenes 81

Veriheal

FEBRUARY 19, 2021

The lack of research is one of the many reasons that cannabis remains federally illegal. But one of the barriers to conducting the necessary research is its federally illegal status. These intertwining factors plaguing cannabis research must be eradicated for the sake of medical cannabis consumers. . Cannabinoids.

Legalization 72

Legalization Research and Development Safety Data 72

Cannabis Law Report

JANUARY 10, 2022

Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

SpeedWeed

MARCH 21, 2021

With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status. The cannabinoid Delta-8-THC is a natural component of cannabis, Russo says. “[W]ith Where It Comes From. RELATED: U.S.

Research and Development 52

Research and Development Hydroponic DEA Cannabinoids 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. 561-627-9455.

DEA 66

DEA Clinical Trials THC Research and Development 66

The Cannigma

JUNE 23, 2022

While CBG (cannabigerol) has been hailed ‘the mother of all cannabinoids,’ it’s time to reveal the true heir to the throne – cannabigerolic acid, or CBGA. This cannabinoid has only recently been studied, and future studies will certainly divulge its exact importance. What is the difference between CBG and CBGa? What does CBGA do?

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

NOVEMBER 10, 2019

The Partnership Seeks to Develop Cannabis-Based Products for the Treatment of Human Diseases, Beginning with Colon Cancer. CIB has a national reputation as a center of excellence for biological research,” said Brian Baca, CEO of Ikänik Farms. “We VANCOUVER, British Columbia, Nov.

Research and Development 45

Research and Development Seed-To-Sale Treatment Cultivation 45

The Cannigma

DECEMBER 14, 2021

Hexahydrocannabinol (HHC), which was patented in the late 1940s as a “therapeutic substance having marihuana activity,” is a cannabinoid that’s growing in popularity and availability. HHC was synthesized in Adams’ laboratory as part of research to understand the active compounds in the cannabis plant. Hexahydrocannabinol (HHC).

Research and Development 116

Research and Development Cannabinoids Clinical Trials THC 116

Cannabis Law Report

JULY 26, 2021

(VANCOUVER, BC , July 26, 2021)— Trait Biosciences ( [link] ), a leading cannabinoid biotechnology research organization, announced that it has completed a C$31 million (US$25.46 Our mission is to develop the world’s most comprehensive integrated approach to cannabinoid science, insights, and technology.

Research and Development 98

Research and Development Cannabinoids Environment Banking 98